14 publications

Name Date Type Actions

Programme de rachat - Décembre 2021

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres.

 		04/01/2022 Monthly communication regarding buyback programs

Double-digit growth in 2021

Total Group Sales: €521 million (up 21.9% as reported)
Annual Sale of Essential products: €296 million (up 34.0% as reported)

 		20/01/2022 Public releases

Buyback programs - January 2022

 		07/02/2022 Monthly communication regarding buyback programs

Buyback programs - february 2022

Buyback programs - February 2022

 		04/03/2022 Monthly communication regarding buyback programs

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

 		24/03/2022 Public releases

Buyback programs - march 2022

Monthly communication regarding buyback programs

 		06/04/2022 Monthly communication regarding buyback programs

Q1 2022 SALES: €135M

Q1 2022 SALES: €135M
(UP 5.5% AS REPORTED, UP 2.2% AT CONSTANT EXCHANGE RATES)
Q1 2022 ESSENTIALS SALES: €77M
(UP 8.1% AS REPORTED, UP 5.5 AT CONSTANT EXCHANGE RATES)

 		13/04/2022 Public releases

Availability of the 2021 universal registration document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

 		22/04/2022 Public releases

Buyback programs - april 2022

Monthly communication regarding buyback programs

 		05/05/2022 Monthly communication regarding buyback programs

Buyback programs - may 2022

Monthly communication regarding buyback programs

 		03/06/2022 Monthly communication regarding buyback programs